Use of Intrathecal Baclofen in Children and Adolescents: Interdisciplinary Consensus Table 2013

Abstract

In recent years, intrathecal baclofen (ITB) has attained an important role in the treatment of severe spasticity and dystonia in children. There are principal differences between the use of ITB in children and its use in neurology and oncology in adults. Here, we present a consensus report on best practice for the treatment of severe spastic and dystonic movement disorders with ITB. Using a problem-orientated approach to integrate theories and methods, the consensus was developed by an interdisciplinary group of experienced ITB users and experts in the field of movement disorders involving 14 German centers. On the basis of the data pooled from more than 400 patients, the authors have summarized their experience and supporting evidence in tabular form to provide a concise, but still a comprehensive information base that represents our current understanding regarding ITB treatment options in children and adolescents.

Keywords

intrathecal baclofen - spasticity - dystonia - children

^* The ITB Working Party comprises A. Flechtenmacher (Gelsenkirchen), K. Keun-Sun (Heidelberg), K. Koch (Heidelberg), B. Kretzschmar (Eisenach), P. Kunkel (Hamburg-Altona), A. Lohr (Erfurt), B. Marks (Berlin), A. Merkenschlager (Leipzig), K. Müller (Meerbusch), A. Sarpong (Berlin).

Note: This consensus statement has been acknowledged by the boards of the following societies:

• Gesellschaft für Neuropädiatrie (GNP, Society for Neuropediatrics) (S.B.)

• Deutsche Gesellschaft für Anästhesiologie und lntensivmedizin (DGAI, German Society of Anaesthesiology and Intensive Care Medicine) (M.K.H.)

• Deutsche Gesellschaft für Kinderchirugie (DGKCH, German Society for Paediatric Surgery (DGKCH) (L.B.)

• Arbeitsgemeinschaft Niedergelassener Neuropädiater (AG NPP, Working Party of Paediatric Neurologists in Private Practice) (S.A.)

• Deutsche Gesellschaft für Sozialpädiatrie und Jugendmedizin (DGSPJ, German Society for Social Paediatrics (DGSPJ) (W.B.)

• References

• 1 Novartis Pharma. Lioresal® intrathecal. Summary of Product Characteristics [Fachinformation]. Available at: http://www.medicines.org.uk/emc/medicine/1295/SPC/lioresal+intrathecal Accessed August 9, 2011
• 2 Dan B, Motta F, Vles JS , et al. Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity. Eur J Paediatr Neurol 2010; 14 (1) 19-28
• 3 Delgado MR, Hirtz D, Aisen M , et al; Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2010; 74 (4) 336-343
• 4 Heinen F, Desloovere K, Schroeder AS , et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 2010; 14 (1) 45-66
• 5 Dralle D, Müller H, Zierski J, Klug N. Intrathecal baclofen for spasticity. Lancet 1985; 2 (8462) 1003
• 6 Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991; 265 (11) 1418-1422
• 7 Albright AL, Ferson SS. Intrathecal baclofen therapy in children. Neurosurg Focus 2006; 21 (2) e3
• 8 Albright AL. Intrathecal baclofen for childhood hypertonia. Childs Nerv Syst 2007; 23 (9) 971-979
• 9 Tilton A. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol 2009; 16 (2) 82-89
• 10 Stevenson VL. Rehabilitation in practice: Spasticity management. Clin Rehabil 2010; 24 (4) 293-304
• 11 Butler C, Campbell S ; AACPDM Treatment Outcomes Committee Review Panel. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol 2000; 42 (9) 634-645
• 12 Al Khudhairi D, Aldin AS, Hamdan Y , et al. Continual infusion of intrathecal baclofen (ITB): long-term effect on spasticity. Middle East J Anaesthesiol 2010; 20 (6) 851-855
• 13 Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003; 98 (2) 291-295
• 14 Albright AL, Awaad Y, Muhonen M , et al. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 2004; 101 (1, Suppl): 64-68
• 15 Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997; 87 (3) 409-414
• 16 Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R. Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol 2003; 18 (1) 26-34
• 17 Campbell WM, Ferrel A, McLaughlin JF , et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 2002; 44 (10) 660-665
• 18 Dralle D, Neuhäuser G, Tonn JC. Intrathecal baclofen for cerebral spasticity. Lancet 1989; 2 (8668) 916
• 19 Gilmartin R, Bruce D, Storrs BB , et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 2000; 15 (2) 71-77
• 20 Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Dev Med Child Neurol 2004; 46 (8) 548-552
• 21 Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Becher JG, Vles JS ; Dutch Study Group on Child Spasticity. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial. Eur J Paediatr Neurol 2009; 13 (3) 240-246
• 22 Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Sleypen FA, Vles JS ; Dutch Study Group on Child Spasticity. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study. Dev Med Child Neurol 2007; 49 (9) 654-659
• 23 Hoving MA, van Raak EP, Spincemaille GH , et al; Dutch Study Group on Child Spasticity. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol 2009; 13 (3) 247-256
• 24 Lapeyre E, Kuks JB, Meijler WJ. Spasticity: revisiting the role and the individual value of several pharmacological treatments. NeuroRehabilitation 2010; 27 (2) 193-200
• 25 McCoy AA, Fox MA, Schaubel DE, Ayyangar RN. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. Arch Phys Med Rehabil 2006; 87 (11) 1503-1508
• 26 Murphy NA, Irwin MC, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil 2002; 83 (12) 1721-1725
• 27 Ramstad K, Jahnsen R, Lofterod B, Skjeldal OH. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?. Acta Paediatr 2010; 99 (11) 1661-1665
• 28 Scheinberg A, O'Flaherty S, Chaseling R, Dexter M. Continuous intrathecal baclofen infusion for children with cerebral palsy: a pilot study. J Paediatr Child Health 2001; 37 (3) 283-288
• 29 Vloeberghs M, Keetley R, Morton R. Intrathecal baclofen in the management of spasticity due to cerebral palsy. Pediatr Rehabil 2005; 8 (3) 172-179
• 30 Voss W, Gad D, Mücke K-H , et al. Intrathekale Baclofentherapie. Palliativmaßnahme bei spastischen und dystonen Bewegungsstörungen. Monatsschr Kinderheilkd 2009; 157: 1128-1136
• 31 Ward A, Hayden S, Dexter M, Scheinberg A. Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment. J Paediatr Child Health 2009; 45 (12) 720-726
• 32 Gray N, Morton RE, Brimlow K, Keetley R, Vloeberghs M. Goals and outcomes for non ambulant children receiving continuous infusion of intrathecal baclofen. Eur J Paediatr Neurol 2012; 16 (5) 443-448
• 33 Gray N, Vloeberghs M. The effect of continuous intrathecal baclofen on sitting in children with severe cerebral palsy. Eur J Paediatr Neurol 2014; 18 (1) 45-49
• 34 Morton RE, Gray N, Vloeberghs M. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy. Dev Med Child Neurol 2011; 53 (8) 736-741
• 35 Motta F, Antonello CE, Stignani C. Intrathecal baclofen and motor function in cerebral palsy. Dev Med Child Neurol 2011; 53 (5) 443-448
• 36 Pritula SL, Fox MA, Ayyangar R. Weight changes in children receiving intrathecal baclofen for the treatment of spasticity. J Pediatr Rehabil Med 2012; 5 (3) 197-201
• 37 Vles GF, Soudant DL, Hoving MA , et al. Long-term follow-up on continuous intrathecal Baclofen therapy in non-ambulant children with intractable spastic Cerebral Palsy. Eur J Paediatr Neurol 2013; 17 (6) 639-644
• 38 Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984; 1 (8385) 1078
• 39 Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet 1985; 2 (8447) 125-127
• 40 Kluger G, Lütjen S, Granel M. Die intrathekale Baclofentherapie (ITB) bei Kindern mit schwerer Spastik und/oder Dystonie: 15 Jahre Erfahrung bei 68 Patienten. Neuropadiatr Klin Prax 2003; 1: 18-24
• 41 Hoarau X, Richer E, Dehail P, Cuny E. Comparison of long-term outcomes of patients with severe traumatic or hypoxic brain injuries treated with intrathecal baclofen therapy for dysautonomia. Brain Inj 2012; 26 (12) 1451-1463
• 42 Posteraro F, Calandriello B, Galli R, Logi F, Iardella L, Bordi L. Timing of intrathecal baclofen therapy in persons with acquired brain injury: influence on outcome. Brain Inj 2013; 27 (13-14) 1671-1675
• 43 Bonouvrié LA, van Schie PE, Becher JG, van Ouwerkerk WJ, Vermeulen RJ. Intrathecal baclofen for progressive neurological disease in childhood: a systematic review of literature. Eur J Paediatr Neurol 2012; 16 (3) 279-284
• 44 Pratini NR, Sweeters N, Vichinsky E, Neufeld JA. Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen. Am J Phys Med Rehabil 2013; 92 (8) 728-733
• 45 Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology 1991; 41 (7) 1141-1142
• 46 Motta F, Antonello CE, Stignani C. Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia. J Pediatr Orthop 2009; 29 (7) 817-821
• 47 Bonouvrié LA, van Schie PE, Becher JG, van Ouwerkerk WJ, Reeuwijk A, Jeroen Vermeulen R. Effects of intrathecal baclofen on daily care in children with secondary generalized dystonia: a pilot study. Eur J Paediatr Neurol 2011; 15 (6) 539-543
• 48 Bahl A, Tripathi C, McMullan J, Goddard J. Novel use of intrathecal baclofen drug delivery system for periodic focal dystonia in a teenager. Neuromodulation 2013; 16 (3) 273-275
• 49 Grosso S, Verrotti A, Messina M, Sacchini M, Balestri P. Management of status dystonicus in children. Cases report and review. Eur J Paediatr Neurol 2012; 16 (4) 390-395
• 50 Brochard S, Lempereur M, Filipetti P, Rémy-Néris O. Changes in gait following continuous intrathecal baclofen infusion in ambulant children and young adults with cerebral palsy. Dev Neurorehabil 2009; 12 (6) 397-405
• 51 Brochard S, Remy-Neris O, Filipetti P, Bussel B. Intrathecal baclofen infusion for ambulant children with cerebral palsy. Pediatr Neurol 2009; 40 (4) 265-270
• 52 Pin TW, McCartney L, Lewis J, Waugh MC. Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review. Dev Med Child Neurol 2011; 53 (10) 885-895
• 53 Vles JS. Intrathecal baclofen therapy in non-ambulant and ambulant children and adolescents with spasticity of cerebral origin. Dev Med Child Neurol 2011; 53 (11) 1061 , author reply 1062–1063
• 54 Palisano RJ, Hanna SE, Rosenbaum PL , et al. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther 2000; 80 (10) 974-985
• 55 Rosenbaum PL, Walter SD, Hanna SE , et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA 2002; 288 (11) 1357-1363
• 56 Bjornson KF, McLaughlin JF, Loeser JD , et al. Oral motor, communication, and nutritional status of children during intrathecal baclofen therapy: a descriptive pilot study. Arch Phys Med Rehabil 2003; 84 (4) 500-506
• 57 Ginsburg GM, Lauder AJ. Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. Spine 2007; 32 (24) 2745-2750
• 58 Burn SC, Zeller R, Drake JM. Do baclofen pumps influence the development of scoliosis in children?. J Neurosurg Pediatr 2010; 5 (2) 195-199
• 59 Gerszten PC, Albright AL, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 1998; 88 (6) 1009-1013
• 60 Aisch A, Kästner S, Lütjen S et al. Spannung lösen–Spastik verringern. Intrathekale Baclofentherapie bei Kindern und Jugendlichen mit schwerer Spastizität für eine erhöhte Lebensqualität. Eine Aufklärungsbroschüre für junge Patienten und Angehörige. Medtronic GmbH
• 61 Hoving MA, van Kranen-Mastenbroek VH, van Raak EP, Spincemaille GH, Hardy EL, Vles JS ; Dutch Study Group On Child Spasticity. Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen. Clin Neurophysiol 2006; 117 (7) 1508-1517
• 62 Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 2007; 107 (1, Suppl): 32-35
• 63 Balch III RJ, Gofeld M. Ultrasound-guided intrathecal baclofen trial: a retrospective case series examining a novel approach. PM R 2011; 3 (5) 486-488
• 64 Bleyenheuft C, Filipetti P, Caldas C, Lejeune T. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy. Neurophysiol Clin 2007; 37 (1) 23-28
• 65 Albright AL, Turner M, Pattisapu JV. Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 2006; 104 (4, Suppl): 233-239
• 66 Ammar A, Ughratdar I, Sivakumar G, Vloeberghs MH. Intrathecal baclofen therapy—how we do it. J Neurosurg Pediatr 2012; 10 (5) 439-444
• 67 Sivakumar G, Yap Y, Tsegaye M, Vloeberghs M. Intrathecal baclofen therapy for spasticity of cerebral origin—does the position of the intrathecal catheter matter?. Childs Nerv Syst 2010; 26 (8) 1097-1102
• 68 Muquit S, Ughratdar I, Ingale H, Vloeberghs M. Cervical catheter placement for intrathecal baclofen test dose: is it safe?. Childs Nerv Syst 2012; 28 (6) 919-922
• 69 Ughratdar I, Muquit S, Ingale H, Moussa A, Ammar A, Vloeberghs M. Cervical implantation of intrathecal baclofen pump catheter in children with severe scoliosis. J Neurosurg Pediatr 2012; 10 (1) 34-38
• 70 Albright AL. Technique for insertion of intraventricular baclofen catheters. J Neurosurg Pediatr 2011; 8 (4) 394-395
• 71 Bollo RJ, Gooch JL, Walker ML. Stereotactic endoscopic placement of third ventricle catheter for long-term infusion of baclofen in patients with secondary generalized dystonia. J Neurosurg Pediatr 2012; 10 (1) 30-33
• 72 Rocque BG, Leland Albright A. Intraventricular vs intrathecal baclofen for secondary dystonia: a comparison of complications. Neurosurgery 2012; 70 (2, Suppl Operative ): 321-325 , discussion 325–326
• 73 Turner M, Nguyen HS, Cohen-Gadol AA. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations. J Neurosurg Pediatr 2012; 10 (4) 315-319
• 74 Albright AL, Shultz BL. Plasma baclofen levels in children receiving continuous intrathecal baclofen infusion. J Child Neurol 1999; 14 (6) 408-409
• 75 Albright AL, Thompson K, Carlos S, Minnigh MB. Cerebrospinal fluid baclofen concentrations in patients undergoing continuous intrathecal baclofen therapy. Dev Med Child Neurol 2007; 49 (6) 423-425
• 76 Heetla HW, Staal MJ, Kliphuis C, van Laar T. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord 2009; 47 (10) 751-756
• 77 Stokic DS, Yablon SA. Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia. Clin Neurophysiol 2012; 123 (11) 2200-2204
• 78 Yang TF, Wang JC, Chiu JW, Lai CJ, Chan RC, Lee SS. Ultrasound-guided refilling of an intrathecal baclofen pump—a case report. Childs Nerv Syst 2013; 29 (2) 347-349
• 79 Silva S, Nowicki P, Caird MS , et al. A comparison of hip dislocation rates and hip containment procedures after selective dorsal rhizotomy versus intrathecal baclofen pump insertion in nonambulatory cerebral palsy patients. J Pediatr Orthop 2012; 32 (8) 853-856
• 80 Miracle AC, Fox MA, Ayyangar RN, Vyas A, Mukherji SK, Quint DJ. Imaging evaluation of intrathecal baclofen pump-catheter systems. AJNR Am J Neuroradiol 2011; 32 (7) 1158-1164
• 81 Dardashti S, Chang EY, Kim RB, Alsharif KI, Hata JT, Perret DM. False positive radiographical evidence of pump catheter migration into the spinal cord. Pain Physician 2013; 16 (5) E627-E630
• 82 Diehn FE, Wood CP, Watson Jr RE, Mauck WD, Burke MM, Hunt CH. Clinical safety of magnetic resonance imaging in patients with implanted SynchroMed EL infusion pumps. Neuroradiology 2011; 53 (2) 117-122
• 83 Borowski A, Littleton AG, Borkhuu B , et al. Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop 2010; 30 (1) 76-81
• 84 Buonaguro V, Scelsa B, Curci D, Monforte S, Iuorno T, Motta F. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy. Pediatr Neurol 2005; 33 (2) 110-113
• 85 Fjelstad AB, Hommelstad J, Sorteberg A. Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 2009; 4 (5) 487-493
• 86 Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 2003; 39 (1) 1-6
• 87 Kofler M, Kronenberg MF, Rifici C, Saltuari L, Bauer G. Epileptic seizures associated with intrathecal baclofen application. Neurology 1994; 44 (1) 25-27
• 88 Kolaski K, Logan LR. A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation 2007; 22 (5) 383-395
• 89 Weber P. Dose-dependent relapse of hiatus hernia after administration of intrathecal baclofen treatment—a rare complication. Childs Nerv Syst 2013; 29 (5) 873-875
• 90 Zdolsek HA, Olesch C, Antolovich G, Reddihough D. Intrathecal baclofen therapy: benefits and complications. J Intellect Dev Disabil 2011; 36 (3) 207-213
• 91 Awaad Y, Rizk T, Siddiqui I, Roosen N, McIntosh K, Waines GM. Complications of intrathecal baclofen pump: prevention and cure. ISRN Neurol 2012; 2012: 575168
• 92 Haranhalli N, Anand D, Wisoff JH , et al. Intrathecal baclofen therapy: complication avoidance and management. Childs Nerv Syst 2011; 27 (3) 421-427
• 93 Taira T, Ueta T, Katayama Y , et al. Rate of complications among the recipients of intrathecal baclofen pump in Japan: a multicenter study. Neuromodulation 2013; 16 (3) 266-272 , discussion 272
• 94 Varhabhatla NC, Zuo Z. Rising complication rates after intrathecal catheter and pump placement in the pediatric population: analysis of national data between 1997 and 2006. Pain Physician 2012; 15 (1) 65-74
• 95 Walter M, Altermatt S, Furrer C, Meyer-Heim A. Intrathecal baclofen therapy in children with severe spasticity: outcome and complications (published ahead of print). Dev Neurorehabil 2013;
• 96 Dickey MP, Rice M, Kinnett DG , et al. Infectious complications of intrathecal baclofen pump devices in a pediatric population. Pediatr Infect Dis J 2013; 32 (7) 715-722
• 97 Hester SM, Fisher JF, Lee MR, Macomson S, Vender JR. Evaluation of salvage techniques for infected baclofen pumps in pediatric patients with cerebral palsy. J Neurosurg Pediatr 2012; 10 (6) 548-554
• 98 Tunali Y, Hanimoglu H, Tanriverdi T, Hanci L, Hanci M. Intrathecal baclofen toxicity and deep coma in minutes. J Spinal Cord Med 2006; 29 (3) 237-239
• 99 Chapple D, Johnson D, Connors R. Baclofen overdose in two siblings. Pediatr Emerg Care 2001; 17 (2) 110-112
• 100 Darbari FP, Melvin JJ, Piatt Jr JH, Adirim TA, Kothare SV. Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features. Pediatr Neurol 2005; 33 (5) 373-377
• 101 Sgouros S, Charalambides C, Matsota P, Tsangaris I, Kostopanagiotou G. Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose. Pediatr Neurosurg 2010; 46 (1) 62-65
• 102 Kramer K, Weber M, Koulousakis A, Lier H, Krep H. Intrathecal baclofen therapy. Overdose during replacement of a medication pump [in German]. Anaesthesist 2009; 58 (9) 891-896
• 103 Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord 2012; 50 (2) 107-111
• 104 Dvorak EM, McGuire JR, Nelson ME. Incidence and identification of intrathecal baclofen catheter malfunction. PM R 2010; 2 (8) 751-756
• 105 Kao LW, Amin Y, Kirk MA, Turner MS. Intrathecal baclofen withdrawal mimicking sepsis. J Emerg Med 2003; 24 (4) 423-427
• 106 Muirhead W, Jalloh I, Vloeberghs M. Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature. J Med Case Reports 2010; 4: 294
• 107 Ross JC, Cook AM, Stewart GL, Fahy BG. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care 2011; 14 (1) 103-108
• 108 Samson-Fang L, Gooch J, Norlin C. Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol 2000; 42 (8) 561-565
• 109 Specchio N, Carotenuto A, Trivisano M, Cappelletti S, Vigevano F, Fusco L. Prolonged episode of dystonia and dyskinesia resembling status epilepticus following acute intrathecal baclofen withdrawal. Epilepsy Behav 2011; 21 (3) 321-323
• 110 Zuckerbraun NS, Ferson SS, Albright AL, Vogeley E. Intrathecal baclofen withdrawal: emergent recognition and management. Pediatr Emerg Care 2004; 20 (11) 759-764
• 111 Kirkham FJ, Haywood P, Kashyape P , et al. Movement disorder emergencies in childhood. Eur J Paediatr Neurol 2011; 15 (5) 390-404
• 112 Hansen CR, Gooch JL, Such-Neibar T. Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report. Arch Phys Med Rehabil 2007; 88 (11) 1468-1471
• 113 Schapiro A, Racadio J, Kinnett D, Maugans T. Combined C-arm fluoroscopy and C-arm cone beam computed tomography for the evaluation of patients with possible intrathecal baclofen delivery system malfunctions. Neurosurgery 2011; 69 (1, Suppl Operative ): ons27-ons33 , discussion ons33
• 114 Teodorczyk J, Szmuda T, Siemiński M, Lass P, Słoniewski P. Evaluation of usefulness of scintigraphic imaging in diagnosis of intrathecal drug delivery system malfunction - a preliminary report. Pol J Radiol 2013; 78 (3) 21-27
• 115 Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology 2005; 64 (6) 1086-1087
• 116 Heinen F, Schröder A, Döderlein L , et al. Grafikgestützter Konsensus für die Behandlung von Bewegungsstörungen bei Kindern mit bilateralen spastischen Cerebralparesen (BS-CP). Therapiekurven-CP Motorik. Monatsschr Kinderheilkd 2009; 157: 789-794
• 117 Barry M, Albright L. Use of the Canadian occupational performance measure as an outcome measure for intrathecal baclofen therapy. Pediatr Phys Ther 1996; 8: 183-184
• 118 Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol 2006; 48 (10) 804-812
• 119 Tsoi WS, Zhang LA, Wang WY, Tsang KL, Lo SK. Improving quality of life of children with cerebral palsy: a systematic review of clinical trials. Child Care Health Dev 2012; 38 (1) 21-31
• 120 Baker KW, Tann B, Mutlu A, Gaebler-Spira D. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ). J Child Neurol 2014; 29 (3) 312-317
• 121 The CPCHILD™ questionnaire. Available at: www.sickkids.ca/Research/CPCHILD-Questionaire/CPCHILD-Project/CPChild-questionaire/index.html . Accessed June 1, 2013